<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Long-standing <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD), either <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> or <z:e sem="disease" ids="C0010346" disease_type="Disease or Syndrome" abbrv="">Crohn disease</z:e>, is associated with a high risk of developing colorectal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (CAC) </plain></SENT>
<SENT sid="1" pm="."><plain>However, histomorphology of IBD-associated CAC has not been thoroughly examined, and it is unclear whether and how these patients should be screened for <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> (LS) </plain></SENT>
<SENT sid="2" pm="."><plain>We evaluated the demographic and morphologic features of 108 IBD-associated CACs, including <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>-associated (n = 95) and <z:e sem="disease" ids="C0010346" disease_type="Disease or Syndrome" abbrv="">Crohn disease</z:e>-associated CACs (n = 13), against 93 control cases of <z:hpo ids='HP_0003745'>sporadic</z:hpo> microsatellite-stable (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>) CAC, 20 cases of <z:hpo ids='HP_0003745'>sporadic</z:hpo> microsatellite instability high (MSI-H) CAC, and 23 CAC cases of LS </plain></SENT>
<SENT sid="3" pm="."><plain>The mean age of patients with IBD-associated CAC was 50 years, which was lower compared with the mean age of 63.7 years of the <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e> controls and 76.5 years of the <z:hpo ids='HP_0003745'>sporadic</z:hpo> MSI-H group but not statistically different from that of the LS patients </plain></SENT>
<SENT sid="4" pm="."><plain>Synchronous CACs were noted in 20.4% of the IBD patients and 13% of LS patients but in only 2.1% of the <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e> controls and in none of the MSI-H patients </plain></SENT>
<SENT sid="5" pm="."><plain>Right-sided CACs were significantly less frequent in the IBD group than in <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e> controls, MSI-H group, and LS patients (P &lt; 0.05 for <z:hpo ids='HP_0000001'>all</z:hpo>) </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast to <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e> CAC, IBD-associated CACs are characterized by lack of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp>, Crohn-like reaction, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> histologic <z:hpo ids='HP_0001425'>heterogeneity</z:hpo>, the presence of mucin, and signet ring cell differentiation and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> well differentiation </plain></SENT>
<SENT sid="7" pm="."><plain>The histomorphologic similarity among IBD-associated and MSI-H <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, either <z:hpo ids='HP_0003745'>sporadic</z:hpo> MSI-H or LS-related, is independent of MSI status </plain></SENT>
<SENT sid="8" pm="."><plain>The young age of patients with IBD-associated CAC and the morphological similarities among IBD-associated, <z:hpo ids='HP_0003745'>sporadic</z:hpo> MSI-H, and LS-related CAC suggest that an age-based and <z:mp ids='MP_0000002'>morphology</z:mp>-based strategy before the screening test for LS may be less effective in IBD patients than in the non-IBD population </plain></SENT>
</text></document>